The Firm’s worldwide healthcare investment strategy involves investing, primarily through equity securities, in healthcare companies throughout the world, with an emphasis on the United States and other developed countries. The strategy employs modest leverage, is broadly diversified by geography and is designed to be 100% or more invested at any time.

Key Highlights

  • Typically invests in companies that range in market capitalization between $500 million and $100 billion.
  • Holds both long and short positions.
  • Broadly diversified by geography and by healthcare subsector with 15% to 20% emerging markets participation.

Emerging Markets

Developed Markets